NO20031814D0 - Behandling av PCP avhengighet og PCP avhengighet-relatert adferd - Google Patents

Behandling av PCP avhengighet og PCP avhengighet-relatert adferd

Info

Publication number
NO20031814D0
NO20031814D0 NO20031814A NO20031814A NO20031814D0 NO 20031814 D0 NO20031814 D0 NO 20031814D0 NO 20031814 A NO20031814 A NO 20031814A NO 20031814 A NO20031814 A NO 20031814A NO 20031814 D0 NO20031814 D0 NO 20031814D0
Authority
NO
Norway
Prior art keywords
pcp addiction
treatment
pcp
addiction
related behavior
Prior art date
Application number
NO20031814A
Other languages
English (en)
Other versions
NO20031814L (no
Inventor
Stephen L Dewey
Jonathan D Brodie
Jr Charles R Ashby
Original Assignee
Brookhaven Science Ass Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brookhaven Science Ass Llc filed Critical Brookhaven Science Ass Llc
Publication of NO20031814D0 publication Critical patent/NO20031814D0/no
Publication of NO20031814L publication Critical patent/NO20031814L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
    • A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0446—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
NO20031814A 2000-10-23 2003-04-23 Behandling av PCP-avhengighet og PCP-avhengighetsrelatert adferd NO20031814L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/694,040 US6395783B1 (en) 2000-10-23 2000-10-23 Treatment of PCP addiction and PCP addiction-related behavior
PCT/US2001/007233 WO2002034249A1 (en) 2000-10-23 2001-03-07 Treatment of pcp addiction and pcp addiction-related behavior

Publications (2)

Publication Number Publication Date
NO20031814D0 true NO20031814D0 (no) 2003-04-23
NO20031814L NO20031814L (no) 2003-06-19

Family

ID=24787164

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031814A NO20031814L (no) 2000-10-23 2003-04-23 Behandling av PCP-avhengighet og PCP-avhengighetsrelatert adferd

Country Status (17)

Country Link
US (1) US6395783B1 (no)
EP (1) EP1335717A4 (no)
JP (1) JP2004512301A (no)
KR (1) KR20030074610A (no)
CN (2) CN1771929A (no)
AU (2) AU4201101A (no)
BR (1) BR0114898A (no)
CA (1) CA2426210C (no)
CZ (1) CZ20031431A3 (no)
HR (1) HRP20030322A2 (no)
HU (1) HUP0301441A3 (no)
IL (2) IL155574A0 (no)
MX (1) MXPA03003589A (no)
NO (1) NO20031814L (no)
NZ (1) NZ526072A (no)
PL (1) PL361028A1 (no)
WO (1) WO2002034249A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
CN114903006B (zh) * 2021-02-09 2024-08-02 中国科学院脑科学与智能技术卓越创新中心 一种非人灵长类动物物质成瘾模型的构建方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2133002B (en) 1982-12-30 1986-01-29 Merrell Toraude & Co Process for preparing 4-amino-5-hexenoic acid
GB8311804D0 (en) 1983-04-29 1983-06-02 Merrell Toraude & Co Treatment of seizure disorders and pharmaceutical compositions
US4595697A (en) 1984-03-28 1986-06-17 Merrell Dow Pharmaceuticals Inc. Treatment of seizure disorders and pharmaceutical compositions useful therein
US5189064A (en) 1985-07-22 1993-02-23 Matrix Technologies, Inc. Treatment of cocaine addiction
WO1989003211A1 (en) 1987-10-07 1989-04-20 Matrix Technologies, Incorporated Treatment of cocaine addiction
US5102913A (en) * 1991-07-01 1992-04-07 Halikas James A Treatment for cocaine use employing valproic acid
IL135659A0 (en) 1997-10-28 2001-05-20 Schering Corp Method of reducing craving in mammals
US6541520B1 (en) * 1998-08-05 2003-04-01 Brookhaven Science Associates Treatment of addiction and addiction-related behavior
ATE294577T1 (de) 1999-02-24 2005-05-15 Univ Cincinnati Verwendung von sulfamat derivaten zur behandlung von impulsiven störungen

Also Published As

Publication number Publication date
CN1771929A (zh) 2006-05-17
CN1476326A (zh) 2004-02-18
AU2001242011B8 (en) 2006-03-02
IL155574A0 (en) 2003-11-23
NO20031814L (no) 2003-06-19
HUP0301441A2 (hu) 2003-11-28
AU2001242011B2 (en) 2005-11-03
CZ20031431A3 (cs) 2004-06-16
US6395783B1 (en) 2002-05-28
HUP0301441A3 (en) 2011-07-28
CN1234352C (zh) 2006-01-04
KR20030074610A (ko) 2003-09-19
CA2426210C (en) 2009-12-22
PL361028A1 (en) 2004-09-20
NZ526072A (en) 2004-08-27
WO2002034249A1 (en) 2002-05-02
HRP20030322A2 (en) 2005-02-28
MXPA03003589A (es) 2005-08-16
EP1335717A4 (en) 2004-06-30
EP1335717A1 (en) 2003-08-20
JP2004512301A (ja) 2004-04-22
CA2426210A1 (en) 2002-05-02
IL155574A (en) 2010-02-17
BR0114898A (pt) 2003-08-12
AU4201101A (en) 2002-05-06

Similar Documents

Publication Publication Date Title
NO20011964D0 (no) Brönnbehandlingsfluider og fremgangsmåter med anvendelse derav
NO20013393D0 (no) Brönnsementeringsfremgangsmåter og sammensetninger
DE60132052D1 (de) Bohr- und Behandlungsflüssigkeiten
NO20032668L (no) Gyraseinhibitorer og anvendelser derav
DK1251848T3 (da) Gyraseinhibitorer og anvendelse deraf
IS6477A (is) Afleiður piperazíns og piperadíns
NO20030725D0 (no) Terapeutisk kombinasjon av CETP-inhibitor og atorvastatin
DK1202941T3 (da) Gipssammensætninger og beslægtede fremgangsmåder
GB0403665D0 (en) Drillable inflatable packer and methods of use
IS7977A (is) Samsetningar og aðferð til samsettra meðferðar
DE60017241D1 (de) Unterwasserbehandlungsanordnung und -verfahren
NO20020343D0 (no) Kaspase-inhibitorer og anvendelse derav
NO20015773D0 (no) Forhindring og behandling av amyloidogen sykdom
AU7593001A (en) Alpha-msh related compounds and methods of use
DK1400518T3 (da) Heterocycliske forbindelser og lægemidler
AU2002361667A8 (en) Non-volatile memory and method of forming thereof
NO20033854D0 (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
DK1322597T3 (da) Fremgangsmåde og intermediære
NO20005440D0 (no) Pakkebaserte personlig utstyrsarrangementer og - fremgangsmÕter
IS2867B (is) Neublastín sem tengt er fjölliðu og aðferðir við notkun þess
DE60120291D1 (de) Endoskop und Endoskopkapsel
NO20031814D0 (no) Behandling av PCP avhengighet og PCP avhengighet-relatert adferd
NO20024974L (no) Nedihulls-pluggholder og fremgangsmåte
NO20032821D0 (no) Sea-trosy og beslektede fremgangsmåter
NO20042126L (no) Syntese av 2-aralkoksyadenosiner og 2-alkoksyadenosiner

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application